Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 3
1996 1
1997 1
1998 1
2000 2
2003 1
2004 2
2007 2
2008 2
2009 4
2010 4
2011 3
2012 1
2013 5
2014 2
2015 1
2016 2
2017 4
2018 1
2019 4
2020 2
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Clinical radioimmunotherapy--the role of radiobiology.
Pouget JP, Navarro-Teulon I, Bardiès M, Chouin N, Cartron G, Pèlegrin A, Azria D. Pouget JP, et al. Among authors: navarro teulon i. Nat Rev Clin Oncol. 2011 Nov 8;8(12):720-34. doi: 10.1038/nrclinonc.2011.160. Nat Rev Clin Oncol. 2011. PMID: 22064461 Review.
Introduction to radiobiology of targeted radionuclide therapy.
Pouget JP, Lozza C, Deshayes E, Boudousq V, Navarro-Teulon I. Pouget JP, et al. Among authors: navarro teulon i. Front Med (Lausanne). 2015 Mar 17;2:12. doi: 10.3389/fmed.2015.00012. eCollection 2015. Front Med (Lausanne). 2015. PMID: 25853132 Free PMC article. Review.
General overview of radioimmunotherapy of solid tumors.
Navarro-Teulon I, Lozza C, Pèlegrin A, Vivès E, Pouget JP. Navarro-Teulon I, et al. Immunotherapy. 2013 May;5(5):467-87. doi: 10.2217/imt.13.34. Immunotherapy. 2013. PMID: 23638743 Review.
[Anti-HER2 vaccines: The HER2 immunotargeting future?].
Ladjemi MZ, Jacot W, Pèlegrin A, Navarro-Teulon I. Ladjemi MZ, et al. Among authors: navarro teulon i. Pathol Biol (Paris). 2011 Jun;59(3):173-82. doi: 10.1016/j.patbio.2009.04.002. Epub 2009 May 28. Pathol Biol (Paris). 2011. PMID: 19481373 Free article. Review. French.
Anti-HER2 vaccines: new prospects for breast cancer therapy.
Ladjemi MZ, Jacot W, Chardès T, Pèlegrin A, Navarro-Teulon I. Ladjemi MZ, et al. Among authors: navarro teulon i. Cancer Immunol Immunother. 2010 Sep;59(9):1295-312. doi: 10.1007/s00262-010-0869-2. Epub 2010 Jun 8. Cancer Immunol Immunother. 2010. PMID: 20532501 Free PMC article. Review.
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.
Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz LB, Roger P, Guiu S, Derocq D, Robin G, Michaud HA, Delpech H, Jarlier M, Pugnière M, Robert B, Puel A, Martin L, Landomiel F, Bourquard T, Achour O, Fruitier-Arnaudin I, Pichard A, Deshayes E, Turtoi A, Poupon A, Simony-Lafontaine J, Boissière-Michot F, Pirot N, Bernex F, Jacot W, du Manoir S, Theillet C, Pouget JP, Navarro-Teulon I, Bonnefoy N, Pèlegrin A, Chardès T, Martineau P, Liaudet-Coopman E. Ashraf Y, et al. Among authors: navarro teulon i. J Immunother Cancer. 2019 Feb 4;7(1):29. doi: 10.1186/s40425-019-0498-z. J Immunother Cancer. 2019. PMID: 30717773 Free PMC article.
46 results